Healthcare systems are rapidly integrating artificial intelligence to improve patient outcomes. However, the Radiology AI economic impact remains poorly understood due to fragmented evidence. A recent systematic review analysed thirty-one studies to clarify how AI affects medical imaging budgets and clinical value. This data is particularly vital for Indian hospitals facing a significant shortage of specialists.
Understanding Radiology AI Economic Impact
The review identified that only sixteen out of thirty-one studies conducted a full economic evaluation. Researchers found that quality-adjusted life years (QALYs) served as the primary measure of effectiveness. Furthermore, many evaluations focused on direct costs and diagnostic accuracy rather than long-term savings. Consequently, the quality of reporting varied significantly across the literature. Most studies utilized decision-analytic modeling to estimate potential financial outcomes. However, a major geographic bias exists, as most evidence originates from the United States and the United Kingdom.
Challenges in Assessing Clinical Value
Clinicians often struggle to justify AI investments without robust local data. For instance, few studies assessed workflow efficiency or physician productivity gains. Moreover, international guidance remains limited for harmonizing economic metrics. In India, where the doctor-to-patient ratio is roughly 1:900, AI could dramatically bridge access gaps. Early reports suggest AI-powered diagnostics can reduce reporting times by nearly 46 percent. Therefore, future research must shift focus toward real-world implementation costs and broader societal benefits.
Future Directions for Responsible Adoption
Responsible AI integration requires interdisciplinary collaboration between radiologists and economists. Standardized approaches will enable better comparison between different software solutions. Additionally, health systems should prioritize metrics relevant to local decision-making. International bodies now recommend using tools like CHEERS-AI to improve reporting transparency. By establishing clear value propositions, healthcare providers can ensure technology serves both patients and budgets effectively. Ultimately, harmonised global standards will support evidence-based transitions into digital-first radiology departments.
Frequently Asked Questions
Q1: Which metrics are most commonly used to evaluate the economic value of AI?
Most evaluations use quality-adjusted life years (QALYs), cost per patient screened, and incremental cost-effectiveness ratios. However, direct costs and diagnostic accuracy also remain frequent focal points in the literature.
Q2: Why is the geographic distribution of AI economic research problematic?
The current evidence predominantly comes from the US and UK, which may not reflect the cost structures of other regions. India, for example, requires specific data that accounts for its unique patient load and resource constraints.
References
-
- Gregory L et al. Economic evaluations of AI applications in radiology: a systematic review. Eur Radiol. 2026 Feb 20. doi: 10.1007/s00330-025-12308-3. PMID: 41718863.
-
- Sanders GD et al. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. JAMA. 2016;316(10):1093–1103.
-
- Madaan S et al. India emerging as leader in AI adoption; healthcare, diagnostics lead charge. Medical Buyer. 2025 Apr 9.